Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1980 1
1993 1
1995 2
1997 4
1998 2
1999 1
2000 1
2001 2
2002 4
2004 3
2005 7
2006 4
2007 7
2008 8
2009 7
2010 5
2011 5
2012 5
2013 6
2014 6
2015 7
2016 9
2017 7
2018 3
2019 8
2020 16
2021 7
2022 13
2023 14
2024 9
2025 17
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Results by year

Filters applied: . Clear all
Page 1
Chronopharmacology of glucocorticoids.
Scherholz ML, Schlesinger N, Androulakis IP. Scherholz ML, et al. Among authors: schlesinger n. Adv Drug Deliv Rev. 2019 Nov-Dec;151-152:245-261. doi: 10.1016/j.addr.2019.02.004. Epub 2019 Feb 21. Adv Drug Deliv Rev. 2019. PMID: 30797955 Free PMC article. Review.
Pegloticase.
Schlesinger N, Yasothan U, Kirkpatrick P. Schlesinger N, et al. Nat Rev Drug Discov. 2011 Jan;10(1):17-8. doi: 10.1038/nrd3349. Nat Rev Drug Discov. 2011. PMID: 21193861 No abstract available.
Dr. Schlesinger replies.
Schlesinger N. Schlesinger N. J Rheumatol. 2016 Aug;43(8):1617. doi: 10.3899/jrheum.160394. J Rheumatol. 2016. PMID: 27481992 No abstract available.
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions.
Schlesinger N, Alten RE, Bardin T, Schumacher HR, Bloch M, Gimona A, Krammer G, Murphy V, Richard D, So AK. Schlesinger N, et al. Ann Rheum Dis. 2012 Nov;71(11):1839-48. doi: 10.1136/annrheumdis-2011-200908. Epub 2012 May 14. Ann Rheum Dis. 2012. PMID: 22586173 Clinical Trial.
Canakinumab in gout.
Schlesinger N. Schlesinger N. Expert Opin Biol Ther. 2012 Sep;12(9):1265-75. doi: 10.1517/14712598.2012.705825. Epub 2012 Jul 12. Expert Opin Biol Ther. 2012. PMID: 22784099 Review.
Updates in uricase therapy for gout.
Schlesinger N, Kaufmann D. Schlesinger N, et al. Curr Opin Rheumatol. 2025 Nov 1;37(6):422-429. doi: 10.1097/BOR.0000000000001122. Epub 2025 Sep 3. Curr Opin Rheumatol. 2025. PMID: 40916989 Review.
Management of gout.
Perez-Ruiz F, Schlesinger N. Perez-Ruiz F, et al. Among authors: schlesinger n. Scand J Rheumatol. 2008 Mar-Apr;37(2):81-9. doi: 10.1080/03009740701867372. Scand J Rheumatol. 2008. PMID: 18415763 Review. No abstract available.
175 results